Shareholders that lost money on Agenus Inc.(AGEN) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More

Core Viewpoint - A class action securities lawsuit has been filed against Agenus Inc. due to alleged securities fraud affecting investors between January 23, 2023, and July 17, 2024 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that the defendants made false statements regarding the effectiveness of their immuno-oncology products, botensilimab and balstilimab, which were overstated in terms of clinical results and regulatory prospects [2]. - Investors who suffered losses during the specified timeframe have until November 5, 2024, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving in this role [2]. Group 2: Legal Representation - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the United States [3].